1-6 of 6
Mazhar Adli
Close
Save search
Sort by
Journal Articles

Characterizing Transcriptional and Epigenetic Signatures Induced By FLT3-ITD Activation

Free
Barbara Spitzer, MD, Olga A Guryanova, MD PhD, Omar Abdel-Wahab, MD, Nicole Kucine, MD, Mazhar Adli, PhD, Jason N. Berman, MD, Soheil Meshinchi, MD PhD, Bradley Bernstein, MD PhD, Raphael Pelossof, PhD, Christina Leslie, PhD, Ross L. Levine, MD
Journal: Blood
Blood (2014) 124 (21): 2186.
https://doi.org/10.1182/blood.V124.21.2186.2186
Published: 2014
Journal Articles

Structural and Functional Studies Of The Intrinsically Disordered Protein AF9 In MLL-AF9 Leukemia

Free
Aravinda Kuntimaddi, Alyson Lokken, Shubin Zhang, Jeremy Thorpe, Benjamin Leach, PhD, Bhavna Lumba, PhD, Charles S. Hemenway, MD, PhD, Mazhar Adli, PhD, Nancy J. Zeleznik-Le, PhD, John H. Bushweller, PhD
Journal: Blood
Blood (2013) 122 (21): 3762.
https://doi.org/10.1182/blood.V122.21.3762.3762
Published: 2013
Journal Articles

Conditional Deletion of Asxl1 Results in Myelodysplasia

Free
Omar Abdel-Wahab, M.D., Jie Gao, PhD, Mazhar Adli, PhD, Young Rock Chung, MSc, Richard Koche, PhD, Alan H. Shih, MD, PhD, Suveg Pandey, BSc, Lindsay M. La-Fave, PhD, Delphine Ndiaye-Lobry, Yu Sup Shin, BSc, Parva K. Bhatt, BSc, Jay P. Patel, Xinyang Zhao, PhD, Christopher Y. Park, MD, PhD, Jacob D. Jaffe, PhD, Bradley E. Bernstein, MD, PhD, Iannis Aifantis, PhD, Ross L. Levine
Journal: Blood
Blood (2012) 120 (21): 308.
https://doi.org/10.1182/blood.V120.21.308.308
Published: 2012
Journal Articles

ASXL1 Mutations Promote Myeloid Transformation Through Inhibition of PRC2-Mediated Gene Repression

Free
Omar Abdel-Wahab, MD, Mazhar Adli, PhD, Lindsay Saunders, B.Sc., Jie Gao, PhD, Alan H. Shih, MD, PhD, Suveg Pandey, B.Sc., Jake Jaffe, PhD, Xinyang Zhao, PhD, Fabiana Perna, MD, Martin Carroll, MD, Ari Melnick, MD, Stephen D. Nimer, MD, Iannis Aifantis, PhD, Bradley Bernstein, Ross L Levine, MD
Journal: Blood
Blood (2011) 118 (21): 405.
https://doi.org/10.1182/blood.V118.21.405.405
Published: 2011
Journal Articles

Heterodimeric JAK-STAT Activation As a Mechanism of Persistence to JAK2 Inhibitor Therapy

Free
Neha Bhagwat, Priya Koppikar, Outi Kilpivaara, Taghi Manshouri, PhD, Mazhar Adli, Ann Mullally, MD, Omar Abdel-Wahab, MD, Laura Leung, Abby Weinstein, Sachie Marubayashi, Aviva Goel, Mithat Gonen, Zeev Estrov, Benjamin L. Ebert, MD, D.Phil, Gabriela Chiosis, PhD, Bradley Bernstein, Srdan Verstovsek, MD, PhD, Ross L Levine, MD
Journal: Blood
Blood (2011) 118 (21): 122.
https://doi.org/10.1182/blood.V118.21.122.122
Published: 2011
Journal Articles

HOXA9 Is a Novel Therapeutic Target in Multiple Myeloma.

Free
Michael A Chapman, Jean-Philippe Brunet, Jonathan J Keats, PhD, Angela Baker, Mazhar Adli, Anna C. Schinzel, Gregory Ahmann, BS, Harview Christina, Anna Moore, Vijayalakshmi Shanmugam, Louise M. Perkins, PhD, Daniel Auclair, PhD, William C. Hahn, MD, PhD, Bradley E. Bernstein, MD, Leif Bergsagel, Rafael Fonseca, John Carpten, Jeffrey Trent, Todd R. Golub, MD
Journal: Blood
Blood (2009) 114 (22): 832.
https://doi.org/10.1182/blood.V114.22.832.832
Published: 2009